OXYGEN ABUNDANCE AND ENERGY DEPOSITION IN THE SLOW CORONAL WIND

Observations of the extended corona obtained with the Ultraviolet Coronagraph Spectrometer (UVCS) on board the Solar and Heliospheric Observatory (SOHO) during the solar minimum years 1996 and 1997 have been analyzed to derive the oxygen abundance in the outer corona. A comparison of the absolute coronal abundance, measured in the coronal regions surrounding the quiescent solar minimum streamers, to the heliospheric values confirms that these regions are the dominant sources of the slow solar wind. However, the inferred coronal abundances are consistent with the heliospheric values only in case the ion velocity distribution is anisotropic and enhanced across the coronal magnetic field. Thus this analysis also leads to the conclusion that energy is deposited in the slow coronal wind at least up to 2.7 R☉ and that the efficiency of energy deposition is likely to be related to the local coronal magnetic topology

MULTI-FLUID MODEL OF A STREAMER AT SOLAR MINIMUM AND COMPARISON WITH OBSERVATIONS

We present the results of a time-dependent 2.5-dimensional three-fluid magnetohydrodynamic model of the coronal streamer belt, which is compared with the slow solar wind plasma parameters obtained in the extended corona by the UV spectroscopic data from the Ultraviolet Coronagraph Spectrometer (UVCS) on board SOHO during the past minimum of solar activity (Carrington Rotation 1913). Our previous three-fluid streamer model has been improved by considering the solar magnetic field configuration relevant for solar minimum conditions, and preferential heating for O5 + ions. The model was run until a fully self-consistent streamer solution was obtained in the quasi-steady state. The plasma parameters from the multi-fluid model were used to compute the expected UV observables from H I Lyα 1216 A and O VI 1032 A spectral lines, and the results were compared in detail with the UVCS measurements. A good agreement between the model and the data was found. The results of the study provide insight into the acceleration and heating of the multi-ion slow solar wind

Particle monitoring capability of the Solar Orbiter Metis coronagraph through the increasing phase of solar cycle 25

Context. Galactic cosmic rays (GCRs) and solar particles with energies greater than tens of MeV penetrate spacecraft and instruments hosted aboard space missions. The Solar Orbiter Metis coronagraph is aimed at observing the solar corona in both visible (VL) and ultraviolet (UV) light. Particle tracks are observed in the Metis images of the corona. An algorithm has been implemented in the Metis processing electronics to detect the VL image pixels crossed by cosmic rays. This algorithm was initially enabled for the VL instrument only, since the process of separating the particle tracks in the UV images has proven to be very challenging. Aims. We study the impact of the overall bulk of particles of galactic and solar origin on the Metis coronagraph images. We discuss the effects of the increasing solar activity after the Solar Orbiter mission launch on the secondary particle production in the spacecraft. Methods. We compared Monte Carlo simulations of GCRs crossing or interacting in the Metis VL CMOS sensor to observations gathered in 2020 and 2022. We also evaluated the impact of solar energetic particle events of different intensities on the Metis images. Results. The study of the role of abundant and rare cosmic rays in firing pixels in the Metis VL images of the corona allows us to estimate the efficiency of the algorithm applied for cosmic-ray track removal from the images and to demonstrate that the instrument performance had remained unchanged during the first two years of the Solar Orbiter operations. The outcome of this work can be used to estimate the Solar Orbiter instrument's deep charging and the order of magnitude for energetic particles crossing the images of Metis and other instruments such as STIX and EUI.Comment: 8 pages, 6 figure

SWELTO - Space WEather Laboratory in Turin Observatory

SWELTO - Space WEather Laboratory in Turin Observatory is a conceptual framework where new ideas for the analysis of space-based and ground-based data are developed and tested. The input data are (but not limited to) remote sensing observations (EUV images of the solar disk, Visible Light coronagraphic images, radio dynamic spectra, etc...), in situ plasma measurements (interplanetary plasma density, velocity, magnetic field, etc...), as well as measurements acquired by local sensors and detectors (radio antenna, fluxgate magnetometer, full-sky cameras, located in OATo). The output products are automatic identification, tracking, and monitoring of solar stationary and dynamic features near the Sun (coronal holes, active regions, coronal mass ejections, etc...), and in the interplanetary medium (shocks, plasmoids, corotating interaction regions, etc...), as well as reconstructions of the interplanetary medium where solar disturbances may propagate from the Sun to the Earth and beyond. These are based both on empirical models and numerical MHD simulations. The aim of SWELTO is not only to test new data analysis methods for future application for Space Weather monitoring and prediction purposes, but also to procure, test and deploy new ground-based instrumentation to monitor the ionospheric and geomagnetic responses to solar activity. Moreover, people involved in SWELTO are active in outreach to disseminate the topics related with Space Weather to students and the general public

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication